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A dvocacy is "the giving of public support to an idea, a course of action or a belief." 1 Diseaserelated advocacy groups provide education, raise awareness, and engage in legislative, scientific, and regulatory processes to advance funding and treatments for a variety of diseases. Well-recognized advocacy efforts among patients living with human immunodeficiency virus (HIV)/AIDS and breast cancer have yielded increased research funding for and public awareness of these conditions. [2] [3] [4] Although more than 25 million Americans have chronic kidney disease (CKD) and more than 400,000 require maintenance dialysis therapy, CKD research funding is relatively low and public awareness of the impact of CKD is limited.
5, 6 Improved understanding of advocacy knowledge and interest among patients living with CKD is vital. Such understanding may help us identify strategies to promote increased patient involvement in advocacy and thus strengthen the community's effort to enhance CKD-related education and funding and stimulate new treatment development.
Patient involvement in health-related advocacy is one form of patient "engagement," a broad term used to capture a patient's ability to obtain the "greatest benefit from available health care services."
7 Data demonstrate that patients who are more active in their care are more successful in self-management behaviors, such as medication adherence, and have better outcomes, including greater quality of life and fewer hospitalizations, compared with less activated patients. 8, 9 Social context and personal experiences shape people's understanding of their own health and roles in health-related activities such as advocacy. 10 Better understanding of the patient perspective is needed to promote patient advocacy.
Patients receiving maintenance dialysis represent an ideal population for studying advocacy because the prevailing culture of in-center dialysis facilitates frequent congregation, patient interaction, and educational opportunities, factors known to catalyze interest group mobilization. [11] [12] [13] Despite these seemingly advantageous environmental factors, participation in CKD-related advocacy among patients on dialysis therapy is generally perceived as low in the CKD community. Advocacy groups such as the National Kidney Foundation, American Association of Kidney Patients, and Dialysis Patient Citizens exist, but their reach is not well described.
We undertook this qualitative research to elicit knowledge and perceptions of CKD-related advocacy among patients receiving maintenance dialysis. Additionally, we sought to garner patient input about preferred modes of communication and ideas for generating advocacy enthusiasm in the dialysis community. Findings may inform initiatives to better engage patients in CKD advocacy from the local dialysis unit to the national level.
METHODS
We followed the Consolidated Criteria for Reporting Qualitative Health Research (COREQ). 14 
Participant Selection and Setting
Dialysis patients were eligible to participate if they were 18 years or older, had been on dialysis therapy for 6 months or longer, and were English speaking. Patients with a functioning kidney transplant or cognitive impairment or who were medically unstable per their nephrologist were excluded.
Kidney disease advocacy was defined as the act of speaking out on behalf of persons with CKD or on behalf of a CKD-related cause. We used purposive iterative sampling to capture a range of demographic (age, sex, race, and education level) and advocacy-related characteristics and promote content saturation.
15
Participants were recruited from 3 dialysis facilities in North Carolina and from patient advocacy group listservs. This 2-pronged approach facilitated capture of diverse advocacy experiences. To minimize selection bias in local patient recruitment, we assigned all facility patients unique identifiers. A random number generation program stratified by demographic characteristics (age, sex, and race) was then used to select 30 local patients for the initial recruitment phase. Because many local participants met nonadvocate criteria, we sought to identify nonadvocates from other geographic regions using snowball sampling (ie, chain referral sampling) by interview participants. 16, 17 National participants shared the recruitment e-mail with interested acquaintances. Interested individuals then contacted study staff, and study staff performed eligibility screening and consent. All participants provided written informed consent. Participants were reimbursed $75 for their time. This study was approved by the University of North Carolina at Chapel Hill Institutional Review Board (study number 15-1941).
Data Collection
We developed a semistructured interview guide based on literature review and research team discussions (Table S1 , available as online supplementary material). A pilot interview was conducted with a dialysis patient to evaluate interview guide terminology and length. Interviews were conducted from September through November 2015 by an experienced field interviewer (G.S.S.). Interviews with participants from North Carolina were performed in person, and interviews with participants from other states were performed over the telephone. In-person interviews occurred at a venue of the participant's choosing. Interviews were not conducted during dialysis treatments. Participant recruitment was stopped when content saturation was reached. Data saturation was reached when no new concepts emerged in subsequent interviews and further data coding was not feasible. 18 Due to the wide range of advocacy activities and experiences reported, more advocate (n 5 30) than nonadvocate (n 5 18) interviews were required to achieve data saturation. Interviews were recorded and transcribed. Field notes were taken during interviews. Demographic and clinical characteristics were self-reported.
Data Analysis
Participants were categorized across 5 levels of advocacy behavior based on their highest level of CKD advocacy involvement: (1) none, (2) individual (spoke out on behalf of self in relation to CKD care), (3) dialysis unit (spoke out on behalf of others in relation to CKD care at the dialysis unit level, included serving as a peer mentor), (4) community (spoke out on behalf of a person with CKD or a CKD-related cause at the city or state level), and (5) national (spoke out on behalf of a person with CKD or a CKD-related cause at the national level). Participants in levels 3 to 5 met our a priori definition of CKD advocates. Participants in levels 1 to 2 were classified as nonadvocates. Participant characteristics were described across advocacy status as count and proportion for categorical variables and mean 6 standard deviation for continuous variables. Bivariable comparisons were made using Fisher exact test for categorical variables and Wilcoxon-MannWhitney test for continuous variables.
Transcribed interviews were entered into ATLAS.ti software for qualitative data analysis (version 7). Coding was performed independently by 2 team members (G.S.S. and J.B.W). Team members used the principles of grounded theory and thematic analysis to code the transcriptions into concepts and themes. [19] [20] [21] Thematic development was inductive and performed without reliance on a priori themes. The software was used to generate concept reports with corresponding quotations. Preliminary concepts were compared and reviewed by G.S.S., J.B.W., and J.E.F. to ensure that the identified concepts were in agreement and reflected the data's range and depth (investigator triangulation). An analytical framework was reached through an iterative process of analysis and theme comparison across investigators (G.S.S., J.B.W., and J.E.F.). Conceptual patterns and links among themes were identified and a thematic schema was developed with input from all authors. Figure S1 and Table S2 display additional participant characteristics.
RESULTS

Participant and Interview Characteristics
Of 48 participants, 30 (63%) met our definition of CKD advocates. Advocacy activities were diverse and included informing a clinic manager about an unsafe facility parking lot, giving a CKD education session at a church, walking in a kidney fundraiser event, and participating in lobbyist activities (Box 1). Twentythree of the 48 (48%) interviews were conducted in person. Interview duration ranged from 29 to 162 minutes (mean, 78.9 6 32.9 minutes).
Themes
Five major themes describing participants' perceptions of dialysis patient involvement in CKD advocacy were identified: (1) advocacy awareness, (2) willingness to participate, (3) personal motivations, (4) resources, and (5) mobilization experience. Each theme and corresponding subthemes are described next. Tables 2 and S3 display illustrative quotations for themes and subthemes. Figure 1 presents a schematic of the conceptual links among themes and subthemes, illustrating a pathway to advocacy involvement.
Advocacy Awareness
Better understanding of advocacy than engagement. Most participants demonstrated understanding of advocacy, describing it as "speaking out," "standing up," or "promoting a cause." Very few participants were unfamiliar with the term. A few displayed advanced understanding, acknowledging an advocacy spectrum from personal to population health. Several made a distinction between personal advocacy that related to "getting the best care possible" and national advocacy that involved population-level "lobbying."
In contrast, most participants had poor understanding of the term "patient engagement." One participant answered that engagement meant "getting hitched with somebody," while another described it as "scheduling and organizing." A few were familiar with engagement, defining it as "proactiveness" in one's own health care.
Lack of concrete knowledge about kidney disease advocacy. Most participants displayed operational understanding of CKD advocacy, identifying examples of CKD advocacy activities such as "kidney walks" and patient support groups. Many were aware of national advocacy organization existence, but were unable to name specific organizations and were unsure how to access them: "I think there's a lot of people out there that want to do it, but they don't know how to find each other." In discussing dialysis unit level advocacy, multiple participants cited a need for patient-led support groups but were either unsure how to connect with such groups or believed none existed in their areas.
Lack of publicity surrounding kidney disease. Several participants commented on the lack of commercials and public information on CKD compared with other diseases such as cancer or heart disease. One participant noted that CKD advocacy may be limited by the tendency of patients living with CKD, who often have comorbid conditions, to identify with other non-kidney-focused disease groups such as diabetes and vasculitis advocacy groups.
Factors Influencing Willingness to Participate
Personal qualities. Many participants identified intrinsic qualities as predisposing some people to advocacy participation. For example, several commented that "introverts" might be less likely to participate. Patient "inertia" and dialysis community "complacency" were identified as barriers. Among participants with extensive CKD advocacy involvement, many identified community service as part of their identities.
Internal and external efficacy. The majority of participants reported confidence in their personal abilities to participate in advocacy. Almost all participants thought that their ability to participate in advocacy was equal to or greater than that of other dialysis patients. In general, participants thought that self-confidence in one's ability to understand and participate in advocacy was critical to involvement. Many cited strong public speaking, writing, and organizational skills as important. Several believed that these skill sets were what motivated a key figure to invite them to participate in advocacy. Many noted that advocacy participation might help build selfconfidence.
External efficacy was also identified as important. Many participants did not think their voice would be heard. Some cited lack of historical advances in dialysis as evidence that advocacy efforts would not yield desired results. 
Motivations for Participation
Altruism and providing a purpose. Participants active in CKD advocacy reported a desire to give back. Advocacy participation gave many a life purpose, allowing them to focus on causes external to their health. In general, the act of helping others was seen as enhancing to quality of life.
Advancement of personal health and self-education. Many viewed CKD advocacy as a vehicle by which to learn about medical advances and gain education that might enhance their own health.
Personal Resources
Almost all cited limited personal resources and the burden of living with CKD as critical barriers to greater advocacy involvement. One 67-year-old woman commented, "I can barely take care of myself. How am I going to speak up for somebody else?" Time. Most participants cited lack of time as a critical barrier for participation, referencing the time burden of dialysis therapy itself as well as time associated with other health care appointments. Many noted the importance of preserving their personal free time, citing hesitation to become involved in activities that might limit this time.
Financial resources and transportation. Several participants listed personal and advocacy group finances as important to successful advocacy. One noted that missed work due to advocacy involvement was a deterrent. Almost all identified lack of transportation as a barrier to advocacy participation.
Health status and energy level. Many participants believed that low energy or feeling "washed out" after treatments prevented involvement in advocacy activities. A few specifically cited depression and apathy as contributors to feelings of unwellness. Factors Affecting Willingness to Participate in Advocacy Personal qualities "Like I said, they don't feel like speaking, they don't feel like talking. They're introverts." (Man, 46 y, advocate) "Because people are different. There are some people who don't even think about the fact that something that they do can make something better or change it and for me, I've always been that type of person." (Woman, 69 y, advocate) "I've always been a people person. I've always been very active in my community, even as a child. So that's just kind of my personality." (Woman, 41 y, advocate) "Inertia. Sadly, so many kidney patients just become complacent. the minute they step incenter, they've given up." (Woman, 63 y, advocate) Internal efficacy "I think people are not confident in their skill level in communicating, but that is nothing that you cannot learn." (Woman, 57 y, advocate) "I think I articulate quite well. I think I have the education, and the skills, and the ability to be able to do it, and that's not being pompous." (Woman, 69 y, nonadvocate) "I think they need a leader who has those abilities. Somebody who can speak well. Somebody who can write well. Organize their thoughts well." (Man, 81 y, advocate) "But once they start opening and contributing to whatever it might be, I think they would find that they'd be contributing a lot more because they'll feel more confident in themselves." (Man, 71 y, nonadvocate) "So if you start at an early time, when you're young, realizing that a voice makes a difference, I
think you keep that all the time. It's just a part of some people-like you're a doer." (Woman, 69 y, advocate) External efficacy "I think they don't see that change will happen as a result of their efforts. I see some of them want to know what they're going to get out of it for themselves. I also see others that feel like, "Nothing has been done for, I believe, 40 years now with dialysis. Why would it change now?" (Woman, 46 y, advocate) "What I would be saying probably wouldn't amount to a hill of beans or whatever, so..." (Man, 62 y, nonadvocate) "I don't think [advocacy] is effective. I don't think it's worth the time and effort you put into it from the results that you get." (Man, 54 y, nonadvocate)
Motivations to Participate in Advocacy Altruism "I believe in being a good steward. You give where you think you're going to get the biggest bang for your buck." (Man, 64 y, advocate) "Lack of funds to get something started and pulled together" (Man, 31 y, nonadvocate) "You need to have the money to plan and organize these activities, whether it's going to DC, whether it's holding a social gathering. So, again, money is a major issue with that." (Man, 51 y, advocate) "Certainly, reimbursement and not losing pay for being away from work would be a big incentive, but those are cost issues, which are sometimes difficult to deal with." (Man, 86 y, advocate) "The biggest issue has been [kidney] groups being close enough to you to get involved." (Man, 60 y, advocate) "For one, they have to have a ride. If they ain't got transportation then they ain't going to want to do it." (Man, 51 y, nonadvocate) Health status and energy level "After starting dialysis I didn't have the energy. I was really working on staying alive and staying upright, so doing anything additional was not possible." (Woman, 37 y, nonadvocate) "Other [obstacles to participation] might be their ability to get around physically, because I see a lot of folks coming in on vans, and they have to wheel them down, and so there may be wheel chairs, and that takes effort." (Man, 71 y, nonadvocate) "A lot of depression, and general not feeling well. You are just trying to hold your life together.
And so I think that's hard for people. But a lot of times they just don't feel good." (Man, 49 y, advocate)
Advocacy Mobilization Experience Key figure invited participation "You have to have someone who motivates them or interests them, puts a little bug in their ear." (Woman, 69 y, advocate) "Someone pushing them [to overcome obstacles to advocacy participation]. Someone coming in and talking to them. Encouraging them, and telling them what to do." (Woman, 65 y, nonadvocate) "So, I had an annoying, renal social worker who saw that I was, I guess, depressed or being apathetic about the whole thing and unengaged. She explained to me that I need to be more involved in this thing since I'm the one being impacted. So, slowly but surely, she got me interested in various organizations and where there were gaps that I could fill." 
Mobilization Experience
Key figure invited participation. In describing their paths to CKD advocacy, many advocates recognized a key figure who directly invited them to participate in an initial advocacy experience. Most often, this key figure was a social worker. Many recounted that the figure recognized their leadership or other personal qualities and mentioned that they thought that they "would be a good person" to participate. Key figure involvement was also important to sustained advocacy involvement, with the majority of participants with ongoing advocacy activity reporting a personal invitation as the gateway to their first experiences.
Modes of communication and mobilization network. There were other paths to involvement. Several participants self-initiated involvement. Examples of self-directed advocacy included starting a community dialysis patient support group and starting a food bank at the dialysis unit. A few responded to signs posted in public places, such as an advertisement for a kidney walk in a shopping center. Several commented on the importance of ongoing contact with the advocacy organization after the initial participatory event. ." (Man, 49 y, advocate) "But once you start donating, then they send you stuff to tell you what's going on." (Woman, 61 y, advocate) "Well, I would probably design something where we can be more educated. First of all, I would educate them more, and then see how by us being more involved, and more excited about it, we could get more people involved." (Woman, 63 y, advocate) "They're in the chair, they don't want other people to get in the chair, so they would speak from their personal point of view what it's been like to them." (Man, 64 y, advocate)
Note: Quotations are from study participants. Advocates included participants who had prior involvement in dialysis unit, community or national level advocacy activities. Nonadvocates included participants who had no past advocacy involvement or individual level advocacy only (spoke out on behalf of self). Most participants stated that reliance on the internet or mailings without personal contact was not enough to spark sustained involvement. Almost all cited the critical importance of incorporating patients into recruitment or educational efforts regarding CKD advocacy. Participants frequently commented on the importance of shared experiences in building trust and cultivating interest. Table 3 displays patient-suggested strategies for increasing involvement in CKD advocacy (Table S4 : illustrative quotations). In-person information sessions and invitations for specific CKD advocacy opportunities were identified as critical. Most participants found printed fliers and on-line resources helpful, but only as follow-up to in-person delivered information. Several suggested using dialysis facility televisions to show videos on advocacy and other educational topics during dialysis. Information delivered by patients at the correct health literacy level was thought to be critical. Additionally, participants identified incentives such as food and prizes and enablers such as sponsored transportation as important. The dialysis facility was identified as the best place to reach patients, as expressed by one patient, a 37-year-old woman: with results shaping a center-based advocacy program (2) Educational conference (2) Contest among patients at a dialysis facility (1) Center-sponsored experiential advocacy opportunity at a local legislative body (1) Interactive website where patients could ask and answer questions (1) You've got a captive audience... So if there were some way to get into the dialysis clinic and if they had paperwork or pamphlets available that they could at least be passed outwe can't go anywhere, we're on a machine-you can at least get that piece of paper in people's hands. You can't make them read it, but you can give them the information. I think a lot of people would like just the fact that they were contacted or were approached as a person. Just that might interest them in being involved.
Suggestions for Stimulating Kidney Disease Advocacy Involvement
Several participants noted that in order for patients to be receptive to information, they needed to be listened to first; as a 44-year-old man said: "A lot of times you just want to be heard, and sometimes being heard is the best treatment in the world."
One participant, a 49-year-old man, recognized the importance of dialysis unit culture:
I think clinics that have mentors and involve patients in how the clinic runs get more patients engaged and involved. It's hard, if you're at a clinic and you're not engaged, to all of a sudden jump on board with some organization-I think that's a difficult leap. The dialysis experience itself needs to be somewhat positive, as much as it possibly can be at least. So I think it all starts at the clinic level.
Overall, participants cited the importance of patient involvement in the development of advocacy education and recruitment efforts, recognizing the importance of tailoring information to local populations. As one 60-year-old man put it, "I think I would let the patients help design it. I think it might be a different answer for every center."
DISCUSSION
Interview participants displayed general understanding of advocacy, but many lacked knowledge about specific opportunities for CKD advocacy participation. Personal qualities and both internal and external efficacy were perceived as important to advocacy participation, as were motivating factors such as altruism, seeking a life purpose, and selfeducation. Not surprisingly, personal resources, including time, transportation, and health status, were also important. Patients cited in-person patient-delivered communication about CKD advocacy as critical to both sparking initial interest and sustaining involvement.
Patient-led advocacy groups representing a spectrum of diseases from HIV/AIDS and breast cancer to rare diseases such as muscular dystrophy have a rich history of raising public awareness, influencing public policy, obtaining increased funding, and advancing scientific developments. Supporters of patients with breast cancer created a national movement by capitalizing on a network of support groups to engage patients and their supporters in efforts to raise money for research. 4, 11 Groups with smaller memberships such as those representing rare diseases such as Duchenne muscular dystrophy have found success by direct interactions with researchers and legislators. 12 Effective mobilization within other disease groups offers encouragement to the kidney community. Notably, our interview participants identified lack of identity of patients with CKD as a potential barrier to this mobilization. Participants noted that patients with CKD often identify with other diseases such as vasculitis or diabetes, potentially diluting focus on CKD-specific issues. Increased patient involvement in CKD advocacy could have a wide-reaching impact by increasing support for patient and family support programs, public awareness and early detection, research funding, treatment advances, and advantageous legislation.
We sought to gain insight into patient knowledge and beliefs about CKD advocacy and identify strategies to galvanize interest in advocacy in the dialysis community. Not surprisingly, patients believed that attributes such as an outgoing personality, altruism, or desire to expand health knowledge facilitate advocacy participation. Similarly, resources including time, transportation, and health factored heavily into patient perceptions about ability to participate. While participants cited resources as critically important, study participants who classified as advocates hailed from a range of socioeconomic backgrounds, suggesting that resource barriers can be overcome by motivated patients. Additionally, many participants thought that the government would not respond to patient-voiced issues. Low advocacy involvement among patients on dialysis therapy may be a self-fulfilling prophecy: patients believe their voices will not be heard, so they do not speak out. Encouraging patients who have participated in successful patient-led advocacy efforts to speak to fellow patients about their experience may help change perceptions about the effectiveness of advocacy efforts.
Specific skill sets such as speaking, writing, and organizing were cited as important by many participants. Notably, several believed that a key figure invited them to participate in advocacy because of such skill sets. Many of the nonadvocate participants stated that they had never been invited to participate and were not aware of opportunities. This suggests that providers may selectively invite patients to participate. Interestingly, the majority of interview participants (both advocates and nonadvocates) thought that they have the ability to participate in advocacy, suggesting that typical patient selection approaches may overlook potential advocates. It is likely that provider bias and false assumptions about patient interest and ability may unintentionally limit outreach to interested and capable individuals who might not meet the "typical" advocate profile. Educational and recruitment efforts should be aimed at all patients. Furthermore, we were surprised at the large proportion of participants who participated in center-level advocacy activities such as speaking out about patient care or facility condition concerns. Patients with the ability and willingness to speak out on behalf of others at the local level likely have the capacity to become advocates outside the center as well.
Participants were nearly unanimous in their belief that advocacy education and invitations are best delivered to patients by patients. Trust, empathy, and shared experiences were cited as keys to traction. Also, participants thought that patients, not providers, would be more likely to connect at the appropriate health literacy level. Despite a stated preference for patient-delivered information, most advocates recounted being invited to participate by a key figure, typically someone in a position of power. Most often, this key figure was a dialysis facility social worker. Many dialysis facility social workers are heavily burdened with administrative duties, ranging from patient psychosocial support, transportation facilitation, and insurance and financial difficulty troubleshooting. Without better social worker to patient ratios, a social worker-led advocacy model may be difficult to implement. This staffing reality, coupled with the patient-stated preference for patient-delivered information, suggests that patient champions or advocacy ambassadors within dialysis facilities could play important roles in increasing CKD advocacy. Such a finding is also consistent with data demonstrating peer-mentoring program effectiveness. Peer-mentoring programs have been shown to reduce missed treatments and increase self-efficacy and self-management behaviors. 22 In addition to involving patients in the effort to increase advocacy, participants recommended incorporation of food and social opportunities into advocacy events as means to invoke sentiments of value and appreciation for patients.
Overall, our results suggest that there is untapped advocacy potential within the dialysis community and highlight the need for local in-person patient-led initiatives to increase patient involvement in CKD advocacy. As a 69-year-old woman succinctly pointed out, "Sometimes, you just have to talk to them." 
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